OPIOID DRUGS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2025-2032)

Opioid Drugs Market , By Drug Class (Alkaloids (Morphine, codeine), Semisynthetic Opioids (Oxycodone, Hydrocodone, Hydromorphone), Synthetic Opioids (Fentanyl, Alfentanil)), By Application (Analgesia, Cough Suppression, Diarrhea Suppression, Others), By Route of Administration (Oral, Topical, Parenteral, Others (Intramuscular, etc.)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In: 24 Dec, 2025
Code: CMI1017
Pages: 151
Formats: Excel and PDF
Industry: Pharmaceutical
- Historical Range: 2020 - 2024
- Forecast Period: 2025 - 2032

Opioids are a class of drugs which are largely used for relieving pain. One of the first opioid drugs ‘morphine’ was developed in 1803. Opioid drugs act on the opioid receptors present in the central and peripheral nervous system thus providing relief from pain. Opioid are administered in the form of as oral pills, parenteral, liquids, patches or lozenges. There are different types of prescription opioids available such as fentanyl, oxycodone, morphine, codeine, oxymorphone, and hydrocodone which are prescribed by physicians for treating pain.

Market Dynamics

Increasing R&D in synthesis of hybrids targeting opioid and neurokinin receptors is expected to offer lucrative growth opportunities for market players. For instance, in December 2019, researchers from Medical University of Lodz reported the synthesis, structure–activity relationship, and pharmacological characterization of a series of hybrids combining opioid pharmacophores with either substance P (SP) fragments or neurokinin receptor (NK1) antagonist fragments in order to comprehend the role of the neurokinin system in opioid-induced antinociception.

Key players in the market are focused on product approvals and launches to expand their product portfolio. For instance, in June 2018, AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company received the European Commission (EC) approval for DZUVEO for the management of acute moderate to severe pain in adults in medically monitored settings. The market is witnessing increasing merger and acquisition activities. For instance, Grünenthal acquired the U.S.-based pharmaceutical company ‘Averitas Pharma’ in order to expand its presence in the U.S.

Key features of the study

This report provides an in-depth analysis of global opioids market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global opioids market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd., Johnson & Johnson, Endo International plc, Lupin Limited, Cadila Healthcare Limited, Purdue Pharma L.P., AbbVie Inc., Fresenius Kabi, Mallinckrodt Pharmaceuticals, Pfizer Inc., Rhodes Pharmaceuticals L.P., Sun Pharmaceutical Industries Limited, Nesher Pharmaceuticals (USA) LLC, Amneal Pharmaceuticals LLC, Trevena Inc., and Aurobindo Pharma Limited
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global opioids market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global opioids market

Market Segmentation

Drug Class Insights (Revenue, USD Bn, 2025 - 2032)

Alkaloids
Semisynthetic Opioids
Synthetic Opioids

Application Insights (Revenue, USD Bn, 2025 - 2032)

Analgesia
Cough Suppression
Diarrhea Suppression

Route of Administration Insights (Revenue, USD Bn, 2025 - 2032)

Oral
Topical
Parenteral
Others

Distribution Channel Insights (Revenue, USD Bn, 2025 - 2032)

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Regional Insights (Revenue, USD Bn, 2025 - 2032)

North America

U.S.
Canada

Latin America

Brazil
Argentina
Mexico
Rest of Latin America

Europe

Germany
U.K.
France
Italy
Russia
Rest of Europe

Asia Pacific

China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific

Middle East & Africa

GCC Countries
South Africa
Rest of Middle East & Africa

Key Players Insights

Teva Pharmaceutical Industries Ltd.
Johnson & Johnson
Endo International plc
Lupin Limited
Cadila Healthcare Limited
Purdue Pharma L.P.
AbbVie Inc.
Fresenius Kabi
Mallinckrodt Pharmaceuticals
Pfizer Inc.
Rhodes Pharmaceuticals L.P.
Sun Pharmaceutical Industries Limited
Nesher Pharmaceuticals (USA) LLC
Amneal Pharmaceuticals LLC
Trevena Inc.
Aurobindo Pharma Limited

Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

Market Purview

Report Description

Market Definition and Scope

Executive Summary

Market Snippet, By Drug Class
Market Snippet, By Application
Market Snippet, By Route of Administration
Market Snippet, By Distribution Channel
Market Snippet, By Region
Coherent Opportunity Map (COM)

Market Dynamics, Regulations, and Trends Analysis

Market Dynamics

Drivers
Restraints
Market Opportunities

Impact Analysis
Recent Product Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
Reimbursement Scenario
PEST Analysis
PORTER’S Analysis

Global Opioid Drugs Market, By Drug Class, 2020- 2032, (USD Bn)

Introduction

Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021-2032
Segment Trends

Alkaloids

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Segment Trends

Morphine
codeine

Semisynthetic Opioids

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Segment Trends

Oxycodone
Hydrocodone
Hydromorphone

Synthetic Opioids

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Segment Trends

Fentanyl
Alfentanil

Global Opioid Drugs Market, By Application, 2020-2032, (USD Bn)

Introduction

Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021-2032
Segment Trends

Analgesia

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Segment Trends

Cough Suppression

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Segment Trends

Diarrhea Suppression

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Segment Trends

Global Opioid Drugs Market, By Route of Administration, 2020-2032, (USD Bn)

Introduction

Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021-2032
Segment Trends

Oral

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Segment Trends

Topical

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Segment Trends

Parenteral

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Segment Trends

Others (Intramuscular, etc.)

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Segment Trends

Global Opioid Drugs Market, By Distribution Channel, 2020-2032, (USD Bn)

Introduction

Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021-2032
Segment Trends

Hospital Pharmacies

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

Retail Pharmacies

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

Online Pharmacies

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

Global Opioid Drugs Market, By Region, 2020-2032, (USD Bn)

Introduction

Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021-2032
Segment Trends

North America

Introduction
Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2020 -2032, (USD Bn)
Market Size and Forecast, Y-o-Y Growth and By Application, 2020 -2032, (USD Bn)
Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2020 -2032, (USD Bn)
Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020-2032, (USD Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (USD Bn)

U.S.
Canada

Latin America

Introduction
Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2020 -2032, (USD Bn)
Market Size and Forecast, Y-o-Y Growth and By Application, 2020 -2032, (USD Bn)
Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2020 -2032, (USD Bn)
Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020-2032, (USD Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (USD Bn)

Brazil
Mexico
Argentina
Rest of Latin America

Europe

Introduction
Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2020-2032, (USD Bn)
Market Size and Forecast, Y-o-Y Growth and By Application, 2020 -2032, (USD Bn)
Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2020 -2032, (USD Bn)
Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020-2032, (USD Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (USD Bn)

U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe

Asia Pacific

Introduction
Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2020 -2032, (USD Bn)
Market Size and Forecast, Y-o-Y Growth and By Application, 2020 -2032, (USD Bn)
Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2020 -2032, (USD Bn)
Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020-2032, (USD Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (USD Bn)

China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific

Middle East

Introduction
Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2020 -2032, (USD Bn)
Market Size and Forecast, Y-o-Y Growth and By Application, 2020 -2032, (USD Bn)
Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2020 -2032, (USD Bn)
Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020-2032, (USD Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (USD Bn)

GCC
Israel
Rest of Middle East

Africa

Introduction
Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2020 -2032, (USD Bn)
Market Size and Forecast, Y-o-Y Growth and By Application, 2020 -2032, (USD Bn)
Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2020 -2032, (USD Bn)
Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020-2032, (USD Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (USD Bn)

North Africa
Central Africa
South Africa

Competitive Landscape

Company Profiles

Teva Pharmaceutical Industries Ltd.*

Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies

Johnson & Johnson

Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies

Endo International plc

Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies

Lupin Limited

Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies

Cadila Healthcare Limited

Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies

Purdue Pharma L.P.

Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies

AbbVie Inc.

Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies

Fresenius Kabi

Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies

Mallinckrodt Pharmaceuticals

Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies

Pfizer Inc.

Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies

Rhodes Pharmaceuticals L.P.

Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies

Sun Pharmaceutical Industries Limited

Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies

Nesher Pharmaceuticals (USA) LLC

Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies

Amneal Pharmaceuticals LLC

Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies

Trevena Inc.

Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies

Aurobindo Pharma Limited

Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies

Section

References
Research Methodology
About us and Sales Contact

Limited Time Offer - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now